Overview
- 8 inspections across 8 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-05-16.
At a glance
Inspections
8
Sites
8
Observations
0
Career since
Apr 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Boehringer Ingelheim Fremont, Inc. | 16 May 2024 | Human Drugs | On file |
| Novo Nordisk A/S | 25 Mar 2024 | Human Drugs | On file |
| FUJIFILM Diosynth Biotechnologies Texas, LLC | 7 Jun 2023 | Human Drugs | On file |
| Novo Nordisk Production Belgium SA | 26 Oct 2021 | Human Drugs | On file |
| Par Health USA, LLC | 20 Jul 2021 | Human Drugs | On file |
Sites inspected
Boehringer Ingelheim Fremont, Inc.Fremont, United States1 insp.
Novo Nordisk A/SKalundborg, Denmark1 insp.
FUJIFILM Diosynth Biotechnologies Texas, LLCCollege Station, United States1 insp.
Novo Nordisk Production Belgium SABrussels, Belgium1 insp.
Par Health USA, LLCRochester, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael Shanks2 shared
Abigail V Marella1 shared
Yun Wu1 shared
Ralph M Bernstein1 shared
Laurimer Kuilan-Torres1 shared
Joseph A Piechocki1 shared
Frances Namuswe1 shared
Thuy T Nguyen1 shared
Amanda L Fyles1 shared
Diane L Raccasi1 shared
Full investigator report
Get the verbatim findings behind Lindsey J Brown's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site